


Cardiac Electrophysiologist @Sutterhealth - California Pacific Medical Center. Dad Joke Expert. Views are my own.


The COAST-AF study’s was presented at AHA this weekend. LVZ ablation has a mixed history in the realm of AF ablation with 50% of the 17 RCTs being negative. But there is a nuance there. We know LVZ are associated with worse outcomes but the difference in study result probably reflects the “how” we deal with them. Study targeting homogenization, anchoring lesions, and functional substrates have generally been more positive than those where “isolation” is performed. I suspect the future of persistent AF ablation will represent a convergence of personalized approaches examining substrate and function. This is an important contribution from Pablo Nery and team. Congrats to the team.
Presented at #ScientificSessions26: In a prespecified principal subgroup of patients with low-voltage areas, adjunctive low-voltage area ablation with pulmonary vein isolation was associated with lower atrial arrhythmia recurrence and lower atrial fibrillation burden than pulmonary vein isolation alone. These findings indicate that substrate-guided ablation may have relevance for treatment selection in patients with persistent #AtrialFibrillation who have low-voltage areas identified during mapping. ja.ma/4iFimDE

Pulsed field ablation with a variable loop circular catheter in atrial fibrillation: Acute outcomes from the VARIPURE multicenter study #OpenAccess heartrhythmjournal.com/artic…

#TCT2026 paravalvular leak closure for M3 by Dr David Daniels

Let me start with screw the @washingtonpost they are crap journalists. These are hospital-owned clinics. The hospital controls the billing and collects the facility fee. Yet the Washington Post puts “doctors’ offices” in the headline, leaving readers with the impression that their physician is behind the markup. Misleading BS Patients deserve to know who sets these charges and who collects the money. If the hospital is charging the fee, put the hospital in the headline. Physicians shouldn’t have to answer for a billing policy their employer controls. washingtonpost.com/business/…

Type I, infrahisian second degree AV block. One of the largest HV I have ever recorded Case done with the portable EP recording system KardioSkater.

It’s 2075. There is only one hospital in the entire country. It is 8 square miles in the middle of Kansas and owned by United Healthcare. Premiums are $47,000 per month. The only medications left are Ozempic and boner pills. Life expectancy is 38. Government: “I can’t believe doctors did this to us.”

"Adenosine-sensitivity (termination or transient slowing/suppression) in response to adenosine was 100% sensitive and specific for identifying focal AT mechanisms due to triggered activity or automaticity, respectively. ahajournals.org/doi/10.1161/…

We are just getting started
💊 Quadruple GDMT for HFrEF now costs <$1/day 🤯 $25.21/month for all 4 drugs generic via Cost Plus Drugs 💰 Net savings per patient/year: 🏥 $9,477 vs 2-drug therapy (32× offset) 🚑 $23,470 vs no GDMT (78× offset) More than pays for itself🫀 Implement now!


High-Intensity Ultrasound Catheter Ablation: Transmural Ventricular Lesions Through Transducer-Tissue Contact Sensing @B_Naz_MD @UWCardiology @UWMedHeart heartrhythmjournal.com/artic…

The appearance of kinesin, the motor protein that transports substances inside cells, is so cute.

Doctors when the mandatory online modules are due

One of the best measures of an informed doctor: they never shock w less than maximal energy. Don’t let your friends use less than maximum energy
The largest randomized AF DCCV trial to date shows excellent safety and efficacy with either 200J RBW or 360J BTE shocks. @AndrewNguyen_DO @atwater_brett @ISHVnews ahajrnls.org/4bVOKj2

My next startup idea: use AI to invest in startups. Venture capitalists are currently pouring hundreds of billions of dollars into companies promising to replace doctors, lawyers, engineers and writers. Oddly, no one seems particularly eager to replace venture capitalists. This feels like an oversight. The proposed platform would use AI to source companies, interrogate founders, evaluate markets, benchmark valuations and construct diversified venture portfolios. Essentially, it would perform pattern recognition across thousands of opportunities—without requiring three partner meetings, a warm introduction or having attended Stanford with someone’s roommate. ML based algorithms have demonstrably better performance compared to human VCs when looking at ROIC, survivability after 5 years and ARR. The market opportunity is modest: TAM: 6 billion people. (That is approximately the number of people currently online worldwide. ) Under the admittedly generous assumption that fractional ownership, global distribution and compliant investment structures eventually remove geography, accreditation and minimum-check requirements, nearly every digitally connected adult becomes a potential venture investor. Yes, some of those six billion people are children, have no discretionary capital or believe Bitcoin is a personality trait. This is called “top-down TAM analysis,” and venture capitalists have funded companies using considerably worse assumptions. For discipline, we reduce that universe to a SAM of 1–5%: 1% penetration: 60 million investors 5% penetration: 300 million investors At an average allocation of $1,000: $60–$300 billion in potential deployable capital All subject, of course, to securities laws—which remain annoyingly sentient. The underlying thesis is straightforward. Approximately 35% of VC-backed companies eventually reach an acquisition or IPO, while roughly 65% of venture investments return less than the capital invested. A very small percentage generates most of the industry’s returns. In other words, venture investing is a low-frequency, high-variance prediction business dominated by incomplete information, cognitive bias and a tiny number of outliers. (Talk about finding a machine learning problem with excellent branding!) The AI would not need to be perfect. It would merely need to outperform an industry whose current methodology consists largely of pattern recognition, social proof, herd behavior and explaining afterward why the company everyone funded was “obviously inevitable.” The pitch practically writes itself: Democratizing access to venture returns by replacing gatekeepers with an algorithm trained on the gatekeepers’ mistakes. We are currently pre-revenue, pre-product and pre-regulatory approval. So, naturally, we are raising at a $100 million valuation. Sources for the excessively serious TAM slide: The ITU estimates approximately 6 billion people were online in 2025, while the World Bank reports that 79% of adults globally now have a financial account. h/t to @BrentAWilliams2 for the idea for this post . This is obviously sarcasm and not meant as a slight to my VC buddies (love the Patagonia vest btw); but it highlights a critical point - being successful building scaleable SAAS companies doesn't automatically translate into domain expertise elsewhere. (This doesn't apply to neurosurgeons by the way. We really are THAT smart, good looking and totally humble.) @DrDiGiorgio @SebastianCaliri @anish_koka @mahesh_shenai @ssdhall @operationdanish @neoavatara @ddonoho @tylcole @NBSaphierMD @CanesDavid @DutchRojas @chrissyfarr
Not peer reviewed but some real life " indicative proof" at x.com/nealkhosla/status/2036… . If FDA allowed "AI physicians as a category with human performance as a predicate" we'd have proof very quickly! try AI intake and full process at @CuraiHQ

I'm not mad at this tweet. I admire it. It's a clean piece of political warfare, and most people will never see the machine running underneath it. Here's what it's actually doing. First, it picks the sides before anyone votes: "doctors are melting down" assigns the uniforms: doctors are emotional and losing, the public is calm and free. A whole profession collapsed into one hostile bloc in four words. Then it builds an enemy that can't win: no named doctor, no quoted objection. A specific complaint could be answered; a phantom can't, because there's nothing there to rebut. Then it poisons the jury before the defense speaks. "Elitism about knowing best" pre-labels every physician rebuttal as villainy, so when a real doctor shows up with a real point, the crowd has already been told to ignore it. Then it manufactures consensus, “it's very clear where the public stands," based on nothing, so dissent stops being a position and becomes deviance. You're not disagreeing with him, you're disagreeing with "the public." Then it hides the weak claim behind the strong one. The aggressive claim is that a 20-minute prototype from an art company is great and doctors are elitists for doubting it. The retreat position is "you deserve your own data." Challenge the first, and he falls back to the second. The thing nobody argues with is armor for the thing everybody would. Then it converts a product into a civil right. "As a sovereign individual" turns a scanner subscription into freedom itself, so opposing the gadget reads as opposing your liberty, and the mark picks up the sword and fights for him. And it rigs the whole thing so the other side loses every way. Doctors object, "see, melting down." Doctors go quiet, "see, they can't defend it." Every exit is his. Here's the part that matters: strip the populism, and this is corporate PR. Aim the crowd at a rival professional class so the anger never reaches the actual power, the platform that needs a billion scans a month to hit its number. It's the same operation the PBMs, health systems, and insurers run on you every day. The physician gets targeted in every version because the physician is the one class positioned to name the extraction out loud. The structure is excellent. It's aimed at the wrong target.
doctors are melting down over midjourney's medical imaging tech, despite it making knowledge about your own health cheaper + more accessible it's very clear where the public stands and who can't read the room over their elitism about knowing best as a sovereign individual, you deserve to access your own data, understand risks & make informed decisions about your health